Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center
Background: Cyclophosphamide and mycophenolate are the currently proposed first-line agents for induction in lupus nephritis (LN). In this study, we analysed the response rates with the three different induction regimens currently available for LN. Methods: Patients with biopsy-proven LN with data a...
Saved in:
Main Authors: | Keerthi Talari, Rajendra Varaprasad Irlapati, Megha Uppin, Liza Rajasekhar |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=76;epage=80;aulast=Talari |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01) -
M1 and M2 Macrophage Polarization Correlates with Activity and Chronicity Indices in Lupus Nephritis
by: Chutima Chavanisakun, et al.
Published: (2025-01-01) -
LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
by: I.A. Mormol, et al.
Published: (2022-12-01) -
Impact of anxiety and depression on disease activity and quality of life in patients with lupus nephritis
by: Ritambra Dadwal, et al.
Published: (2023-04-01) -
Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
by: Ankan Jha, et al.
Published: (2022-01-01)